EZH2 inhibition enhances T cell immunotherapies by inducing lymphoma immunogenicity and improving T cell function
2024 · Cancer Cell · 45 citations
https://doi.org/10.1016/j.ccell.2024.11.006
W
Winson Cai
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
45
Papers
316
Citations
8
h-index
7
i10-index
Winson Cai is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: CAR-T cell therapy research & Immunotherapy and Immune Responses & Immune Cell Function and Interaction. The author has an h-index of 8, co-authored 39 publications.
ORCID: 0000-0001-7121-0986Papers by this author
worksINTRAVESICAL MUC16 TARGETING CAR T CELLS FOR ORGAN-CONFINED BLADDER CANCERS
2025 · Urologic Oncology Seminars and Original Investigations · 1 citations
https://doi.org/10.1016/j.urolonc.2024.12.242
A proposed model for the regulation of SDE2 by PCNA-dependent cleavage and degradation.
2016 · Figshare · 0 citations
https://doi.org/10.1371/journal.pgen.1006465.g008
Failure to degrade SDE2 impairs S phase progression and cellular survival.
2016 · Figshare · 0 citations
https://doi.org/10.1371/journal.pgen.1006465.g006
SDE2 depletion causes replication-associated DNA damage and a defect in replication stress response.
2016 · Figshare · 0 citations
https://doi.org/10.1371/journal.pgen.1006465.g005
SDE2 is cleaved at a conserved diglycine motif to release an N-terminal UBL.
2016 · Figshare · 0 citations
https://doi.org/10.1371/journal.pgen.1006465.g001
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat